Special notice, 8(a) set-aside
Transportation and Transit Services
75F40124R00049
Food and Drug Administration, Food and Drug Administration. School and Employee Bus Transportation.
Response deadline
May 16, 2024 at 12:00 PM EDT
Closed 899 days ago. Posted April 18, 2024, first published April 18, 2024. Scheduled to archive May 31, 2024.
Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities
This one closed in 2024
3 like it are open now in school and employee bus transportation
- Department of War Education Activity (DoWEA) - Okinawa Vehicle Lease and On-Board Video Surveillance System (OBVSS)
Department of Defense Education Activity, DOD Education Activity
Sources soughtNAICS 485410Outside the USHE1254-27-RE-OKINAWAVEHICLESCloses in 10 daysNov 11 - RFQ SHUTTLE SERVICES FOR VA CENTRAL CALIFORNIA HEALTH CARE SYSTEM
Department of Veterans Affairs, 261-Network Contract Office 21
SolicitationSDVOSBNAICS 485410Location not published36C26127Q0051Closes in 15 daysNov 16 - DoDEA Daily Commute Student Transportation Services to the Hohenfels Military Community, Germany
Department of Defense Education Activity, Dodea Europe East
Sources soughtNAICS 485410Outside the USHE125426REHOHENFELSCloses in 16 daysNov 17
Description
As published on SAM.gov.
Notice of Fair Opportunity - 8(a) After Exclusion of Sources The US Food and Drug Administration {FDA), Office of Finance Budget Acquisition and Planning, intends to issue a single award from a fair opportunity competition After Exlusion of Sources, based on a result of an RFI 75F40124R00005, issued on 10/06/23 - to provide transportation, transit, and parking related services for the Food and Drug Administration (FDA) Services on the White Oak Campus (WO), located at 10903 New Hampshire Ave, Silver Spring, Maryland 20993. The propose this acquisition After Exclusion of Sources, is for the Government to solicit and negotiate with identified source only.
Interested parties may identify their interests and capabilities, to respond to the requirement within seven (7) days after the publication of this notice. A determination by the Government not to compete this proposed acquisition, as 8(a) Set Aside - After Exclusion of Sources, based upon responses to this notice, is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining, not to conduct a set aside competitive requirement.
No further solicitation is available. FDA will consider all responses received prior to the closing date of this notice and will use responses in determining, whether it is necessary to use full and open competition for this requirement. Responses shall be emailed to Natapol Sirikhan, Natapol.Sirikhan@fda.hhs.gov, by May 16, 2024, 12:00 PM EST.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
Points of contact
- Natapol SirikhanNatapol.Sirikhan@fda.hhs.gov2404028031